Skip to main content
SpringerLink
Log in

Co-expression of interleukin-6 and human growth hormone in apparently normal prostate biopsies that ultimately progress to prostate cancer using low pH, high temperature antigen retrieval

  • Original Paper
  • Published:
Journal of Molecular Histology Aims and scope Submit manuscript

Abstract

Prostate cancer is the most common cancer in American men and the second leading cause of cancer deaths in this group. Both growth hormone (GH) and the inflammatory cytokine interleukin 6 (IL-6) have been implicated in prostate cancer progression. Studies in other systems have shown that an increase in GH results in an increase in IL-6 also. The current study demonstrated a parallel spatial and temporal expression of GH and IL-6 in cells in prostate cancer glandular acina cells. This study cannot determine if this expression is coincidental or causative, but it seems likely that the increase in GH could induce the expression of IL-6, since this is the case in other tissues. Optimal labelling for IL-6 in our study was achieved with low pH, high temperature antigen retrieval.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Akakura K, Suzuki H, Ueda T, Komiya A, Ichikawa T, Igarashi T, Ito H (2003) Possible mechanism of dexamethasone therapy for prostate cancer: suppression of circulating level of interleuin-6. Prostate 56:106–109

    Article  PubMed  CAS  Google Scholar 

  • Chopin LK, Veveris-Lowe TL, Philipps AF, Herington AC (2002) Co-expression of GH and GHR isoforms in prostate cancer cell lines. Growth Horm IGF Res 12:126–136

    Article  PubMed  CAS  Google Scholar 

  • Chung TD, Yu JJ, Spiotto MT, Bartkowski M, Simons JW (1999) Characterization of the role of IL-6 in the progression of prostate cancer. Prostate 38:199–207

    Article  PubMed  CAS  Google Scholar 

  • Culig Z, Bartsch G, Hobisch A (2002) Interleukin-6 regulates androgen receptor activity and prostate cancer cell growth. Mol Cell Endocrinol 197:231–238

    Article  PubMed  CAS  Google Scholar 

  • Fasshauer M, Klein J, Lossner U, Paschke R (2003) Interleukin (IL)-6 mRNA expression is stimulated by insulin, isoproterenol, tumour necrosis factor alpha, growth hormone, and IL-6 in 3T3-L1 adipocytes. Horm Metab Res 35:147–152

    Article  PubMed  CAS  Google Scholar 

  • Giri D, Ozen M, Ittmann M (2001) Interleukin-6 is an autocrine growth factor in human prostate cancer. Am J Pathol 159:2159–2165

    PubMed  CAS  Google Scholar 

  • Goh EL, Pircher TJ, Wood TJ, Norstedt G, Graichen R, Lobie PE (1997) Growth hormone-induced reorganization of the actin cytoskeleton is not required for STAT5 (signal transducer and activator of transcription-5)-mediated transcription. Endocrinology 138:3207–3215

    Article  PubMed  CAS  Google Scholar 

  • Hobisch A, Rogatsch H, Hittmair A, Fuchs D, Bartsch G Jr, Klocker H, Bartsch G, Culig Z (2000) Immunohistochemical localization of interleukin-6 and its receptor in benign, premalignant and malignant prostate tissue. J Pathol 191:239–244

    Article  PubMed  CAS  Google Scholar 

  • Hull KL, Harvey S (2001) Growth hormone: roles in female reproduction. J Endocrinol 168:1–23

    Article  PubMed  CAS  Google Scholar 

  • Ibanez L, Fucci A, Valls C, Ong K, Dunger D, de Zegher F (2005) Neutrophil count in small-for-gestational age children: contrasting effects of metformin and growth hormone therapy. J Clin Endocrinol Metab 90:3435–3439

    Article  PubMed  CAS  Google Scholar 

  • Kaulsay KK, Mertani HC, Tornell J, Morel G, Lee KO, Lobie PE (1999) Autocrine stimulation of human mammary carcinoma cell proliferation by human growth hormone. Exp Cell Res 250:35–50

    Article  PubMed  CAS  Google Scholar 

  • Khorram O, Garthwaite M, Grosen E, Golos T (2001) Human uterine and ovarian expression of growth hormone-releasing hormone messenger RNA in benign and malignant gynecologic conditions. Fertil Steril 75:174–179

    Article  PubMed  CAS  Google Scholar 

  • Lee SO, Lou W, Hou M, de Miguel F, Gerber L, Gao AC (2003) Interleukin-6 promotes androgen-independent growth in LNCaP human prostate cancer cells. Clin Cancer Res 9:370–376

    PubMed  CAS  Google Scholar 

  • Milch RA, Rall DP, Tobie JE (1957) Bone Localization of the Tetracyclines. J Natl Cancer Inst 19:87–93

    PubMed  CAS  Google Scholar 

  • Mukhina S, Mertani H, Guo K, Lee C, PD Gluckman, Lobie P (2004) Phenotypic conversion of human mammary carcinoma cells by autocrine human growth hormone. Proc Natl Acad Sci USA 101:1–6

    Article  Google Scholar 

  • Nakashima J, Tachibana M, Horiguchi Y, Oya M, Ohigashi T, Asakura H, Murai M (2000) Serum interleukin 6 as a prognostic factor in patients with prostate cancer. Clin Cancer Res 6:2702–2706

    PubMed  CAS  Google Scholar 

  • Ogilvy-Stuart AL, Gleeson H (2004) Cancer risk following growth hormone use in childhood: implications for current practice. Drug Saf 27:369–382

    Article  PubMed  CAS  Google Scholar 

  • Pagani S, Meazza C, Travaglino P, De Benedetti F, Tinelli C, Bozzola M (2005) Serum cytokine levels in GH-deficient children during substitutive GH therapy. Eur J Endocrinol 52:207–210

    Article  PubMed  CAS  Google Scholar 

  • Park JI, Lee MG, Cho K, Park BJ, Chae KS, Byun DS, Ryu BK, Park YK, Chi SG (2003) Transforming growth factor-beta1 activates interleukin-6 expression in prostate cancer cells through the synergistic collaboration of the Smad2, p38-NF-kappaB, JNK, and Ras signaling pathways. Oncogene 22:4314–4332

    Article  PubMed  CAS  Google Scholar 

  • Raccurt M, Lobie PE, Moudilou E, Garcia-Caballero T, Frappart L, Morel G, Mertani HC (2002) High stromal and epithelial human gh gene expression is associated with proliferative disorders of the mammary gland. J Endocrinol 175:307–318

    Article  PubMed  CAS  Google Scholar 

  • Royuela M, Ricote M, Parsons MS, Garcia-Tunon I, Paniagua R, de Miguel MP (2004) Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate. J Pathol 202:41–49

    Article  PubMed  CAS  Google Scholar 

  • Schindler AE (2004) Gonadotropin-releasing hormone agonists for prevention of postoperative adhesions: an overview. Gynecol Endocrinol 19:51–55

    Article  PubMed  CAS  Google Scholar 

  • Siejka A, Stepien T, Lawnicka H, Krupinski R, Komorowski J, Stepien H (2005) Effect of the growth hormone-releasing hormone [GHRH(1-44)NH2] on IL-6 and IL-8 secretion from human peripheral blood mononuclear cells in vitro. Endocr Regul 39:7–11

    PubMed  CAS  Google Scholar 

  • Slater M (1999) Mitochondrial DNA damage assessment using fluorescence microscopy quantitation. J Histotechnol 22:17–21

    Google Scholar 

  • Slater M, Murphy CR (1999) Detection of apoptotic DNA damage in prostate hyperplasia using tyramide-amplified avidin-HRP. Histochem J 31:747–749

    Article  PubMed  CAS  Google Scholar 

  • Steiner H, Godoy-Tundidor S, Rogatsch H, Berger AP, Fuchs D, Comuzzi B, Bartsch G, Hobisch A, Culig Z (2003) Accelerated in vivo growth of prostate tumors that upregulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathway. Am J Pathol 162:655–663

    PubMed  CAS  Google Scholar 

  • Swolin D, Ohlsson C (1996) Growth hormone increases interleukin-6 produced by human osteoblast-like cells. J Clin Endocrinol Metab 81:4329–4333

    Article  PubMed  CAS  Google Scholar 

  • Triantafillidis JK, Merikas E, Govosdis V, Konstandellou E, Cheracakis P, Barbatzas C, Tzourmakliotis D, Peros G (2003) Increased fasting serum levels of growth hormone and gastrin in patients with gastric and large bowel cancer. Hepato-Gastroenterology 50(Suppl 2):cclvi–cclx

    PubMed  Google Scholar 

  • Uronen-Hansson H, Allen ML, Lichtarowicz-Krynska E, Aynsley-Green A, Cole TJ, Hoiden-Guthenberg I, Fryklund L, Klein N (2003) Growth hormone enhances proinflammatory cytokine production by monocytes in whole blood. Growth Horm IGF Res 13:282–286

    Article  PubMed  CAS  Google Scholar 

  • Wang P, Li N, Li JS, Li WQ (2002)The role of endotoxin, TNF-alpha, and IL-6 in inducing the state of growth hormone insensitivity. World J Gastroenterol 8:531–536

    PubMed  CAS  MATH  Google Scholar 

  • Yang L, Wang L, Lin HK, Kan PY, Xie S, Tsai MY, Wang PH, Chen YT, Chang C (2003) Interleukin-6 differentially regulates androgen receptor transactivation via PI3K-Akt, STAT3, and MAPK, three distinct signal pathways in prostate cancer cells. Biochem Biophys Res Commun 305:462–469

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

The authors wish to acknowledge the Rebecca L Cooper Medical Research Foundation which provided a grant for this study.

Author information

Authors and Affiliations

  1. School of Medical Sciences, Department of Anatomy and Histology F13, The University of Sydney, Sydney, NSW, 2006, Australia

    M. D. Slater & C. R. Murphy

Authors
  1. M. D. Slater
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. R. Murphy
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to M. D. Slater.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Slater, M.D., Murphy, C. Co-expression of interleukin-6 and human growth hormone in apparently normal prostate biopsies that ultimately progress to prostate cancer using low pH, high temperature antigen retrieval. J Mol Hist 37, 37–41 (2006). https://doi.org/10.1007/s10735-006-9027-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10735-006-9027-8

Keywords

Search

Navigation